Sign up to see all 5.
Sign up to see all 5.
No insider has filed a notice of proposed sale (Form 144) for TriSalus Life Sciences Inc in the last 12 months.
| Holder | Shares | % of company | Change vs last qtr | 8 quarters | Held since | % of their book |
|---|---|---|---|---|---|---|
|
FL
First Light Asset Management, LLC
|
6.6M | 10.64% | +1.5M (+29.3%) | Q1 '26 | 1.8% | |
|
Shares held by quarter
Peak holding6.6M (Q2'26)
Change over 8 quarters+6.6M
Share of the company10.640%
|
||||||
|
B
BlackRock, Inc.
|
2.7M | 4.32% | +1.2M (+77.3%) | 2023 | 0.0% | |
|
Shares held by quarter
Peak holding2.7M (Q2'26)
Change over 8 quarters+2.6M
Share of the company4.320%
|
||||||
28 more super investors behind a free account
See every manager holding TriSalus Life Sciences Inc, how their position has changed, and how long they've held it.
Sign up free| Fund | Position value | Shares | % of company | % of the fund | As of |
|---|---|---|---|---|---|
|
WM
Wasatch Funds Trust
|
$5.7M | 1.4M | 2.31% | 1.02% | March 31, 2026 |
|
VT
Vanguard Index Funds
|
$5.2M | 1.1M | 1.85% | 0.00% | June 30, 2026 |
23 more funds behind a free account
See every fund holding TriSalus Life Sciences Inc and how much of the fund the position is.
Sign up free| Holder | Shares | % of company | Change vs last qtr | 8 quarters | Held since | % of their book |
|---|---|---|---|---|---|---|
|
FE
Frankenius Equity AB
5%+ holder
13D · 14.0%
|
7.0M | 11.35% | — | — |
— | — |
|
This holder reports through Schedule 13D/G, not a quarterly 13F.
|
||||||
|
MW
Mats Wahlstrom
5%+ holder
13D · 6.0%
|
3.0M | 4.85% | — | — |
— | — |
|
This holder reports through Schedule 13D/G, not a quarterly 13F.
|
||||||
16 more holders behind a free account
See every insider and 5%+ holder of TriSalus Life Sciences Inc.
Sign up freeLoading...